MedPath

An almond, dried grape and dried cranberry (AGC) mix for improving endurance exercise performance in athletes

Not Applicable
Recruiting
Conditions
Cardiovascular fitness
Aerobic fitness
Cardiovascular - Normal development and function of the cardiovascular system
Musculoskeletal - Normal musculoskeletal and cartilage development and function
Registration Number
ACTRN12618000360213
Lead Sponsor
Professor Jon Buckley
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
108
Inclusion Criteria

Male and aged 18-60 years.
*Non-smoker (minimum 6 months).
*Competitive standard cyclist or triathlete (minimum 6 months training at least 3 times per week)
*Have not consumed greater than 30 g/day of nuts or nut products (e.g. butter, meal, oil etc.) during the four weeks prior to familiarisation.
*Have not consumed greater than 50 g/day of grapes and/or sultanas or grape juice (greater than 1 litre week) during the four weeks prior to familiarisation.
*Have not consumed greater than 50 g/day fresh or dried cranberries or greater than 1 litre/day of cranberry juice during the four weeks prior to familiarisation.
*No allergies to almonds, sultanas or cranberries
*Do not answer yes to any question on page 1 of the Exercise and Sport Science Australia, Sports Medicine Australia and Fitness Australia Adult Pre-Exercise Health Screening Tool.

Exclusion Criteria

Participants will be excluded from the study if they meet any of the following criteria:
*Have a cardiovascular or metabolic condition that imposes a health risk during exercise.
*Have a gastrointestinal disorder that effects nutrient absorption.
*Regularly use any medication or supplements that may alter heart rate (HR) or exercise performance
*Regularly use anti-inflammatory drugs.
*Are unable to chew hard foods such as nuts.
*Take vitamin, mineral, herbal supplementation or medications that may have an impact on study outcomes.
*Are already involved in another research project within 30 days of commencement of the present study that in the opinion of the investigators may influence the outcomes for this study.
*Are unwilling to provide urine samples or have blood withdrawn via venepuncture.
*Show unwillingness to be randomised to either experimental group.
*Failure to satisfy the investigator regarding suitability to participate for any other reason.
*Are unwilling or unable to provide written consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath